SCHEMBL19966969

SCHEMBL19966969

CC(C)N(C)CCNC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24515158 0.87
SCHEMBL19966990 0.82
SCHEMBL25566785 0.78 CYP2C19 (0.35)
SCHEMBL13166556 0.78 MEN1 (0.40)
SCHEMBL19286534 0.74
SCHEMBL14176492 0.74 CA12 (0.33)
SCHEMBL21126648 0.74 CYP2C9 (0.40)
SCHEMBL2604979 0.74 PRMT3 (0.48)
SCHEMBL15467596 0.73 CYP2C19 (0.38)
Hydrochloric Acid SCHEMBL3176008 0.72 PRMT3 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3290419-B1 FUSED-RING OR TRICYCLIC ARYL PYRIMIDINE COMPOUND USED AS KINASE INHIBITOR GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD (CN) 2019-08-07 EP disclosed
US-20180072704-A1 Fused-Ring Or Tricyclic Aryl Pyrimidine Compound Used As Kinase Inhibitor GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-15 US disclosed